President Obama Honors Outstandin?g Early-Care?er NIH Scientists
President Obama has chosen 20 NIH scientists for this year’s Presidential Early Career Award for Scientists and Engineers (PECASE), the highest honor bestowed by the US government to outstanding scientists and engineers beginning their independent careers.
“This presidential award is extremely prestigious and recognizes the achievements of scientists early in their career,” said NIH Director Francis S. Collins, MD, PhD. “These scientists have demonstrated the value of their current work along with the promise of future discoveries to improve the health of our nation. We are very excited about the new PECASE recipients.”
Since the programme began in 1996, NIH has funded 233 PECASE recipients. The NIH awardees will take their places along with 102 other highly accomplished scientists from a number of federal agencies. Of the 20 NIH honorees, 17 are new investigators working at institutions around the nation. The others have positions in the NIH Intramural Programs.
A complete list of NIH-supported PECASE recipients and programme information is available at http://grants.nih.gov/grants/policy/pecase.htm. Awardees will be honored by the President at a White House ceremony sometime in 2014.
The White House announcement is available at: www.whitehouse.gov/the-press-office/2013/12/23/president-obama-honors-outstanding-early-career-scientists
Related News
-
News Eli Lilly gets ready to launch five new drugs in 2023
Eli Lilly, the American pharmaceutical company (IN, USA) are gearing up for a big year ahead, with hopes to launch five new drugs and capitalise on growing obesity and Alzheimer’s disease markets. -
News Amgen buys Horizon for $27.8 billion in bold step into the rare disease market
Amgen Inc buys pharmaceutical company Horizon Therapeutics in a multibillion-dollar deal, in hopes to capitalise on it's portfolio of drugs in the highly sort after rare disease market. -
News Pharma Supply Chain People Moves
The latest appointments and promotions across the pharmaceutical supply chain. -
News Merck to donate new Ebola vaccine to defend against outbreaks in Uganda
Pharmaceutical giant Merck has announced they will be speeding up the processing of a new vaccine against the latest strain of the Ebola virus, to be donated to a global non-profit organisation for distribution -
News CPHI Podcast Series: Driving innovation with pharmaceutical startups
The latest episode in the CPHI Podcast Series explores how startups are driving innovation by taking high-risk approaches and doing business with greater agility. -
News Greener and efficient processes: Quaternary Ammonium Salts
Quaternary Ammonium Salts play a crucial part in Organic Chemistry processes at many major industries. Discover why.
-
News Biosimilars save patients $11B annually, but barriers to adoption remain in US market
Biosimilars introduce competition into the biologics market, driving down prices and increasing patient access. -
News WHO recommends use of two monoclonal antibody treatments against Ebola
The health body recommended use of treatments by Regeneron and Ridgeback Bio
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance